Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ELDN
Eledon Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close
Aug 7, 2026 3:59:59 PM EDT
3.69USD+6.792%(+0.23)929,297
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 6, 2026 9:24:30 AM EDT
3.49USD+0.867%(+0.03)0
After-hours
Aug 7, 2026 4:30:30 PM EDT
3.82USD+3.326%(+0.12)75,814
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 27, 2021
05:18PM EST  Eledon Pharmaceuticals, Inc. (Eledon) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today announced that members of management will be participating in two upcoming virtual investor conferences:   GlobeNewswire Inc
Nov 24, 2021
06:15AM EST  HC Wainwright & Co. Maintains Buy on Eledon Pharmaceuticals, Lowers Price Target to $25   Benzinga
Nov 12, 2021
07:47AM EST  The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares   Benzinga
Nov 11, 2021
04:32PM EST  Eledon Pharmaceuticals Q3 EPS $(0.66) Misses $(0.65) Estimate   Benzinga
04:06PM EST  Nearing full enrollment in ALS Phase 2 Study; topline data expected 1H 2022   GlobeNewswire Inc
08:03AM EST  The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts   Benzinga
03:55AM EST  Earnings Scheduled For November 11, 2021   Benzinga
Nov 1, 2021
08:00AM EDT  Eledon Pharmaceuticals to Release Third Quarter Financial Results   GlobeNewswire Inc
Oct 19, 2021
07:30AM EDT  CareDx And Eledon Pharmaceuticals Announce Collaborative Research Agreement   Benzinga
07:00AM EDT  CareDx and Eledon Pharmaceuticals Announce Collaborative Research   GlobeNewswire Inc
Oct 7, 2021
07:51AM EDT  Eledon Pharmaceuticals Announces Presentation On AT-1501 At The Virtual 2021 Northeast Amyotrophic Lateral Sclerosis Consortium   Benzinga
07:51AM EDT  Eledon Pharmaceuticals Announces Presentation on AT-1501 at the   GlobeNewswire Inc
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Oct 5, 2021
04:22PM EDT  Eledon Pharmaceuticals Announces Upcoming Presentation On AT-1501 At Virtual 2021 International Pancreas And Islet Transplantation Association Congress Oct. 22   Benzinga
04:22PM EDT  Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501   GlobeNewswire Inc
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
Oct 1, 2021
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 1, 2021
04:05PM EDT  Eledon Pharmaceuticals to Present at Two Investor Conferences in   GlobeNewswire Inc
Aug 12, 2021
04:38PM EDT  Eledon Pharmaceuticals Q2 EPS $(0.50) Beats $(0.57) Estimate   Benzinga
04:01PM EDT  Received approval from Health Canada to initiate a clinical trial of AT-1501 in kidney transplantation; company expects to initiate trial in Q4 with initial data in late 2022   GlobeNewswire Inc
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 2, 2021
08:05AM EDT  Eledon Pharmaceuticals to Release Second Quarter Financial Results   GlobeNewswire Inc
Jul 29, 2021
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
Jul 26, 2021
08:03AM EDT  Eledon Pharmaceuticals Receives Health Canada Approval To Commence Human Trials To Evaluate AT-1501 In Kidney Transplantation   Benzinga
08:00AM EDT  Interim data expected in late 2022 in a multicenter, open label study to replace tacrolimus with AT-1501   GlobeNewswire Inc
Jul 2, 2021
08:07AM EDT  Eledon Pharma Appoints Jan Hillson To Board   RTTNews
08:00AM EDT  Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of   GlobeNewswire Inc
Jun 29, 2021
04:07PM EDT  Eledon Pharmaceuticals to Present at the Virtual Ladenburg   GlobeNewswire Inc
May 18, 2021
08:00AM EDT  Eledon Pharmaceuticals to Present at the 2021 Jefferies Virtual   GlobeNewswire Inc
May 13, 2021
04:09PM EDT  Eledon Pharmaceuticals Q1 EPS $(0.57) Misses $(0.32) Estimate   Benzinga
04:01PM EDT  Continued enrollment in Phase 2 clinical trial of AT-1501 in amyotrophic lateral sclerosis (ALS)   GlobeNewswire Inc
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 5, 2021
04:01PM EDT  Eledon Pharmaceuticals Announces Upcoming Presentations on AT-1501   GlobeNewswire Inc
May 4, 2021
04:01PM EDT  Eledon Pharmaceuticals to Release First Quarter Financial Results   GlobeNewswire Inc
Apr 27, 2021
07:56AM EDT  Eledon Pharma Stock Jumps Despite FDA Asking For Additional Preclinical Study In Non-Primate Animal Models   Benzinga
06:27AM EDT  SVB Leerink Maintains Outperform on Eledon Pharmaceuticals, Lowers Price Target to $33   Benzinga
Apr 26, 2021
04:08PM EDT  Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation   Benzinga
04:05PM EDT  Eledon Pharmaceuticals, Inc. (Eledon) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), today announced an updated development strategy for AT-1501 in renal transplantation.   GlobeNewswire Inc
Apr 19, 2021
04:05PM EDT  Eledon Pharmaceuticals Continues to Bolster Leadership Team with   GlobeNewswire Inc
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
04:08PM EDT  Eledon Pharmaceuticals FY20 EPS $(15.72) vs $(24.42) In FY19   Benzinga
04:05PM EDT  Continued enrollment in Phase 2 clinical trial of AT-1501 in amyotrophic lateral sclerosis (ALS)   GlobeNewswire Inc
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
04:04AM EDT  Earnings Scheduled For March 30, 2021   Benzinga
Mar 23, 2021
11:26AM EDT  Eledon Pharmaceuticals shares were trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a price target of $25 per share.   Benzinga
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021   Benzinga
08:00AM EDT  Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year   GlobeNewswire Inc
07:29AM EDT  Cantor Fitzgerald Initiates Coverage On Eledon Pharmaceuticals with Overweight Rating, Announces Price Target of $25   Benzinga
Mar 15, 2021
08:02AM EDT  Eledon Pharmaceuticals Appoints Paul Little CFO and Jeff Bornstein Chief Medical Officer   Benzinga
08:00AM EDT  Eledon Pharmaceuticals Strengthens Leadership Team with Chief   GlobeNewswire Inc
Mar 2, 2021
08:00AM EST  Eledon Pharmaceuticals to Present at H.C. Wainwright Global Life   GlobeNewswire Inc
Feb 17, 2021
08:00AM EST  Eledon Pharmaceuticals to Present at 10th Annual SVB Leerink   GlobeNewswire Inc
Feb 8, 2021
10:12AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2021   Benzinga
08:22AM EST  SVB Leerink Initiates Coverage On Eledon Pharmaceuticals with Outperform Rating, Announces Price Target of $34   Benzinga
Jan 19, 2021
05:55PM EST  Eledon Pharmaceuticals to Participate in the Virtual Noble Capital   GlobeNewswire Inc
Jan 4, 2021
08:00AM EST  Eledon to commence trading on the Nasdaq exchange under the ticker ELDN effective tomorrow, January 5, 2021   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC